11798 Federal Register / Vol. 76, No. 42 / Thursday, March 3, 2011 / Notices 

drug products covered by this notice 

that are marketed under an NDC number 

listed with the Agency in full 

compliance with section 510 of the 

FD&C Act before March 2, 2011. As 

previously stated, drug products 

covered by this notice that are currently 

marketed but not listed with the Agency 

on the date of this notice must, as of the 

effective date of this notice, have 

approved applications prior to their 

shipment in interstate commerce. 

Moreover, any person or firm that has 

submitted or submits an application but 

has yet to receive approval for such 

products is still responsible for full 

compliance with this notice. 

V. Discontinued Products 

Some firms may have previously 

discontinued the manufacturing or 

distribution of products covered by this 

notice without removing them from the 

listing of their products under section 

510(j) of the FD&C Act. Other firms may 

discontinue manufacturing or marketing 

listed products in response to this 

notice. Firms that wish to notify the 

Agency of product discontinuation 

should send a letter, signed by the firm’s 

chief executive officer, fully identifying 

the discontinued product(s), including 

NDC number(s), and stating that the 

product(s) has (have) been 

discontinued. The letter should be sent 

to Sakineh Walther (see ADDRESSES). 

Firms should also update the listing of 

their products under section 510(j) of 

the FD&C Act to reflect discontinuation 

of products covered by this notice. FDA 

plans to rely on its existing records, 

including its drug listing records, or 

other available information when it 

targets violations for enforcement 

action. 

This notice is issued under the 

Federal Food, Drug, and Cosmetic Act 

(sections 502 and 505 (21 U.S.C. 352 

and 355)) and under authority delegated 

to the Assistant Commissioner for 

Policy under section 1410.21 of the FDA 

Staff Manual Guide. 

Dated: February 22, 2011. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2011–4703 Filed 3–2–11; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Advisory Committee on Organ 

Transplantation; Notice of Meeting 

AGENCY: Health Resources and Services 

Administration, HHS. 

ACTION: Notice; correction. 

SUMMARY: The Health Resources and 

Services Administration published a 

notice in the Federal Register of 

February 9, 2011 (76 FR 7223–7224) 

announcing an Advisory Committee on 

Organ Transplantation meeting on 

March 8, 2011. The type of meeting, 

time and place have been changed. 

Correction 

In the Federal Register of February 9, 

2011, in FR Doc. 2011–2839, on page 

7223, 2nd column, under the heading 

Department of Health and Human 

Services, Health Resources and Services 

Administration, Advisory Committee on 

Organ Transplantation; Notice of 

Meeting, change the Times and Place to 

read: 

The meeting will be an Audio 

Conference Call on March 8, 2011, from 

12 noon to 4 p.m. EST. To access the 

conference call, call the USA Toll Free 

Number 888–469–1090 and enter the 

Passcode 2741198. The conference call 

leader is Patricia A. Stroup. Participants 

should call no later than 11:45 a.m. EST 

in order for logistics to be set up. 

Participants are asked to register for the 

conference call by contacting Brittany 

Carey, HRM/Professional and Scientific 

Associates (PSA), the logistical support 

contractor for the meeting, at (703) 889– 

9033 or b_carey@team-psa.com. The 

registration deadline is March 7, 2011. 

The Department will try to 

accommodate those wishing to 

participate in the call. 

The next face-to-face ACOT meeting 

is planned for August 2011. Details 

regarding an August meeting will be 

published in a subsequent Federal 

Register notice. 

Reva Harris, 

Acting Director, Division of Policy and 

Information Coordination. 

[FR Doc. 2011–4755 Filed 3–2–11; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Member 

Conflict. 

Date: March 15, 2011. 

Time: 9 a.m. to 10 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Suite 2C212, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Ramesh Vemuri, PhD, 

Chief, Scientific Review Branch, National 

Institute on Aging, National Institutes of 

Health, 7201 Wisconsin Avenue, Suite 2C– 

212, Bethesda, MD 20892, 301–402–7700, 

rv23r@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: February 25, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–4826 Filed 3–2–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 


srobinson on DSKHWCL6B1PROD with NOTICES